<?xml version="1.0" encoding="UTF-8"?>
<!-- This sitemap was dynamically generated on April 3, 2026 at 2:40 pm by All in One SEO v4.9.5.1 - the original SEO plugin for WordPress. -->

<?xml-stylesheet type="text/xsl" href="https://bostonsp.com/default-sitemap.xsl"?>

<rss version="2.0" xmlns:atom="http://www.w3.org/2005/Atom">
	<channel>
		<title>Boston Strategic Partners</title>
		<link><![CDATA[https://bostonsp.com]]></link>
		<description><![CDATA[Boston Strategic Partners]]></description>
		<lastBuildDate><![CDATA[Wed, 30 Apr 2025 12:00:00 +0000]]></lastBuildDate>
		<docs>https://validator.w3.org/feed/docs/rss2.html</docs>
		<atom:link href="https://bostonsp.com/sitemap.rss" rel="self" type="application/rss+xml" />
		<ttl><![CDATA[60]]></ttl>

		<item>
			<guid><![CDATA[https://bostonsp.com/index.php/bsp-leadership/katarina-chin-mba/]]></guid>
			<link><![CDATA[https://bostonsp.com/index.php/bsp-leadership/katarina-chin-mba/]]></link>
			<title>Katarina Chin, MBA</title>
			<pubDate><![CDATA[Wed, 30 Apr 2025 12:00:00 +0000]]></pubDate>
		</item>
					<item>
			<guid><![CDATA[https://bostonsp.com/index.php/company-team/]]></guid>
			<link><![CDATA[https://bostonsp.com/index.php/company-team/]]></link>
			<title>Leadership Team</title>
			<pubDate><![CDATA[Wed, 30 Apr 2025 11:55:50 +0000]]></pubDate>
		</item>
					<item>
			<guid><![CDATA[https://bostonsp.com/index.php/why-bsp/]]></guid>
			<link><![CDATA[https://bostonsp.com/index.php/why-bsp/]]></link>
			<title>Why BSP</title>
			<pubDate><![CDATA[Tue, 03 Jun 2025 14:19:28 +0000]]></pubDate>
		</item>
					<item>
			<guid><![CDATA[https://bostonsp.com/index.php/2023/03/13/a-retrospective-evaluation-of-endo-aortic-balloon-occlusion-compared-to-external-clamping-in-minimally-invasive-mitral-valve-surgery/]]></guid>
			<link><![CDATA[https://bostonsp.com/index.php/2023/03/13/a-retrospective-evaluation-of-endo-aortic-balloon-occlusion-compared-to-external-clamping-in-minimally-invasive-mitral-valve-surgery/]]></link>
			<title>A Retrospective Evaluation of Endo-Aortic Balloon Occlusion Compared to External Clamping in Minimally Invasive Mitral Valve Surgery</title>
			<pubDate><![CDATA[Thu, 24 Aug 2023 19:27:22 +0000]]></pubDate>
		</item>
					<item>
			<guid><![CDATA[https://bostonsp.com/]]></guid>
			<link><![CDATA[https://bostonsp.com/]]></link>
			<title>Home</title>
			<pubDate><![CDATA[Thu, 15 May 2025 14:01:03 +0000]]></pubDate>
		</item>
					<item>
			<guid><![CDATA[https://bostonsp.com/index.php/elementor-hf/footer/]]></guid>
			<link><![CDATA[https://bostonsp.com/index.php/elementor-hf/footer/]]></link>
			<title>Footer</title>
			<pubDate><![CDATA[Tue, 10 Sep 2024 22:46:58 +0000]]></pubDate>
		</item>
					<item>
			<guid><![CDATA[https://bostonsp.com/index.php/app-development/]]></guid>
			<link><![CDATA[https://bostonsp.com/index.php/app-development/]]></link>
			<title>App Development</title>
			<pubDate><![CDATA[Tue, 08 Oct 2024 16:03:01 +0000]]></pubDate>
		</item>
					<item>
			<guid><![CDATA[https://bostonsp.com/index.php/clinical-contract-research-organization-cro-services/]]></guid>
			<link><![CDATA[https://bostonsp.com/index.php/clinical-contract-research-organization-cro-services/]]></link>
			<title>Clinical/Contract Research Organization (CRO) Services</title>
			<pubDate><![CDATA[Tue, 08 Oct 2024 14:09:43 +0000]]></pubDate>
		</item>
					<item>
			<guid><![CDATA[https://bostonsp.com/index.php/careers/healthcare-associate/]]></guid>
			<link><![CDATA[https://bostonsp.com/index.php/careers/healthcare-associate/]]></link>
			<title>Healthcare Associate</title>
			<pubDate><![CDATA[Fri, 06 Mar 2026 13:56:01 +0000]]></pubDate>
		</item>
					<item>
			<guid><![CDATA[https://bostonsp.com/index.php/leveraging-real-world-evidence-for-indication-expansion/]]></guid>
			<link><![CDATA[https://bostonsp.com/index.php/leveraging-real-world-evidence-for-indication-expansion/]]></link>
			<title>Leveraging Real-World Evidence for Indication Expansion</title>
			<pubDate><![CDATA[Thu, 09 Jan 2025 00:12:08 +0000]]></pubDate>
		</item>
					<item>
			<guid><![CDATA[https://bostonsp.com/index.php/bsp-leadership/xuan-jessie-zhang-md-phd/]]></guid>
			<link><![CDATA[https://bostonsp.com/index.php/bsp-leadership/xuan-jessie-zhang-md-phd/]]></link>
			<title>Xuan (Jessie) Zhang, MD, PhD</title>
			<pubDate><![CDATA[Wed, 13 Nov 2024 22:43:45 +0000]]></pubDate>
		</item>
					<item>
			<guid><![CDATA[https://bostonsp.com/index.php/what-we-do/strategic-approach-and-commercialization/]]></guid>
			<link><![CDATA[https://bostonsp.com/index.php/what-we-do/strategic-approach-and-commercialization/]]></link>
			<title>Business and Clinical Strategy</title>
			<pubDate><![CDATA[Wed, 16 Aug 2023 13:55:48 +0000]]></pubDate>
		</item>
					<item>
			<guid><![CDATA[https://bostonsp.com/index.php/website-development-and-maintenance/]]></guid>
			<link><![CDATA[https://bostonsp.com/index.php/website-development-and-maintenance/]]></link>
			<title>Website Development and Maintenance</title>
			<pubDate><![CDATA[Mon, 12 Aug 2024 17:05:05 +0000]]></pubDate>
		</item>
					<item>
			<guid><![CDATA[https://bostonsp.com/index.php/elementor-hf/header/]]></guid>
			<link><![CDATA[https://bostonsp.com/index.php/elementor-hf/header/]]></link>
			<title>Header</title>
			<pubDate><![CDATA[Wed, 22 May 2024 01:07:30 +0000]]></pubDate>
		</item>
					<item>
			<guid><![CDATA[https://bostonsp.com/index.php/health-economic-modeling-solutions/]]></guid>
			<link><![CDATA[https://bostonsp.com/index.php/health-economic-modeling-solutions/]]></link>
			<title>Health Economic Modeling Solutions</title>
			<pubDate><![CDATA[Tue, 04 Jun 2024 16:07:07 +0000]]></pubDate>
		</item>
					<item>
			<guid><![CDATA[https://bostonsp.com/index.php/2023/04/24/allogeneic-transplantation-in-advanced-cutaneous-t-cell-lymphomas-cutallo-a-propensity-score-matched-controlled-prospective-study/]]></guid>
			<link><![CDATA[https://bostonsp.com/index.php/2023/04/24/allogeneic-transplantation-in-advanced-cutaneous-t-cell-lymphomas-cutallo-a-propensity-score-matched-controlled-prospective-study/]]></link>
			<title>Allogeneic transplantation in advanced cutaneous T-cell lymphomas (CUTALLO): a propensity score matched controlled prospective study</title>
			<pubDate><![CDATA[Thu, 24 Aug 2023 19:23:15 +0000]]></pubDate>
		</item>
					<item>
			<guid><![CDATA[https://bostonsp.com/index.php/2021/09/15/association-of-perioperative-hypotension-with-subsequent-greater-healthcare-resource-utilization/]]></guid>
			<link><![CDATA[https://bostonsp.com/index.php/2021/09/15/association-of-perioperative-hypotension-with-subsequent-greater-healthcare-resource-utilization/]]></link>
			<title>Association of perioperative hypotension with subsequent greater healthcare resource utilization</title>
			<pubDate><![CDATA[Thu, 19 Oct 2023 14:35:12 +0000]]></pubDate>
		</item>
					<item>
			<guid><![CDATA[https://bostonsp.com/index.php/2021/04/28/evaluating-a-novel-hemodialysis-central-venous-catheter-cap-in-reducing-bloodstream-infections-a-quality-improvement-initiative/]]></guid>
			<link><![CDATA[https://bostonsp.com/index.php/2021/04/28/evaluating-a-novel-hemodialysis-central-venous-catheter-cap-in-reducing-bloodstream-infections-a-quality-improvement-initiative/]]></link>
			<title>Evaluating a Novel Hemodialysis Central Venous Catheter Cap in Reducing Bloodstream Infections: A Quality Improvement Initiative</title>
			<pubDate><![CDATA[Thu, 19 Oct 2023 14:31:44 +0000]]></pubDate>
		</item>
					<item>
			<guid><![CDATA[https://bostonsp.com/index.php/2023/08/29/antithrombin-concentrates-may-benefit-cardiopulmonary-bypass-patients-with-suspected-heparin-resistance-a-retrospective-analysis-of-real-world-data/]]></guid>
			<link><![CDATA[https://bostonsp.com/index.php/2023/08/29/antithrombin-concentrates-may-benefit-cardiopulmonary-bypass-patients-with-suspected-heparin-resistance-a-retrospective-analysis-of-real-world-data/]]></link>
			<title>Antithrombin concentrates may benefit cardiopulmonary bypass patients with suspected heparin resistance: A retrospective analysis of real-world data</title>
			<pubDate><![CDATA[Thu, 19 Oct 2023 14:17:29 +0000]]></pubDate>
		</item>
					<item>
			<guid><![CDATA[https://bostonsp.com/index.php/2023/10/11/antithrombin-therapy-current-state-and-future-outlook/]]></guid>
			<link><![CDATA[https://bostonsp.com/index.php/2023/10/11/antithrombin-therapy-current-state-and-future-outlook/]]></link>
			<title>Antithrombin Therapy: Current State and Future Outlook</title>
			<pubDate><![CDATA[Thu, 19 Oct 2023 14:14:51 +0000]]></pubDate>
		</item>
					<item>
			<guid><![CDATA[https://bostonsp.com/index.php/client-list/]]></guid>
			<link><![CDATA[https://bostonsp.com/index.php/client-list/]]></link>
			<title>Client List</title>
			<pubDate><![CDATA[Thu, 06 Jun 2024 15:05:40 +0000]]></pubDate>
		</item>
					<item>
			<guid><![CDATA[https://bostonsp.com/index.php/what-we-do/regulatory-strategy/]]></guid>
			<link><![CDATA[https://bostonsp.com/index.php/what-we-do/regulatory-strategy/]]></link>
			<title>Regulatory Strategy</title>
			<pubDate><![CDATA[Mon, 11 Mar 2024 12:12:06 +0000]]></pubDate>
		</item>
					<item>
			<guid><![CDATA[https://bostonsp.com/?elementskit_template=elementskit_lite-template-1716339774]]></guid>
			<link><![CDATA[https://bostonsp.com/?elementskit_template=elementskit_lite-template-1716339774]]></link>
			<title>ElementsKit_Lite Template #1716339774</title>
			<pubDate><![CDATA[Mon, 09 Sep 2024 11:27:25 +0000]]></pubDate>
		</item>
					<item>
			<guid><![CDATA[https://bostonsp.com/index.php/privacy/]]></guid>
			<link><![CDATA[https://bostonsp.com/index.php/privacy/]]></link>
			<title>Privacy</title>
			<pubDate><![CDATA[Mon, 08 Jul 2024 12:55:02 +0000]]></pubDate>
		</item>
					<item>
			<guid><![CDATA[https://bostonsp.com/index.php/legal/]]></guid>
			<link><![CDATA[https://bostonsp.com/index.php/legal/]]></link>
			<title>Legal</title>
			<pubDate><![CDATA[Mon, 08 Jul 2024 12:51:14 +0000]]></pubDate>
		</item>
					<item>
			<guid><![CDATA[https://bostonsp.com/index.php/contact/]]></guid>
			<link><![CDATA[https://bostonsp.com/index.php/contact/]]></link>
			<title>Connect with BSP</title>
			<pubDate><![CDATA[Fri, 22 Sep 2023 16:24:54 +0000]]></pubDate>
		</item>
					<item>
			<guid><![CDATA[https://bostonsp.com/index.php/careers/data-scientist/]]></guid>
			<link><![CDATA[https://bostonsp.com/index.php/careers/data-scientist/]]></link>
			<title>Data Scientist</title>
			<pubDate><![CDATA[Thu, 21 Sep 2023 14:31:06 +0000]]></pubDate>
		</item>
					<item>
			<guid><![CDATA[https://bostonsp.com/index.php/careers/medical-communications-consultant/]]></guid>
			<link><![CDATA[https://bostonsp.com/index.php/careers/medical-communications-consultant/]]></link>
			<title>Medical Communications Consultant</title>
			<pubDate><![CDATA[Thu, 21 Sep 2023 14:28:35 +0000]]></pubDate>
		</item>
					<item>
			<guid><![CDATA[https://bostonsp.com/index.php/careers/real-world-data-programmer/]]></guid>
			<link><![CDATA[https://bostonsp.com/index.php/careers/real-world-data-programmer/]]></link>
			<title>Real-World Data Programmer</title>
			<pubDate><![CDATA[Thu, 21 Sep 2023 14:26:23 +0000]]></pubDate>
		</item>
					<item>
			<guid><![CDATA[https://bostonsp.com/index.php/careers/healthcare-consultant/]]></guid>
			<link><![CDATA[https://bostonsp.com/index.php/careers/healthcare-consultant/]]></link>
			<title>Healthcare Consultant</title>
			<pubDate><![CDATA[Thu, 21 Sep 2023 14:24:42 +0000]]></pubDate>
		</item>
					<item>
			<guid><![CDATA[https://bostonsp.com/index.php/medical-communications-strategy/]]></guid>
			<link><![CDATA[https://bostonsp.com/index.php/medical-communications-strategy/]]></link>
			<title>Medical Communications Strategy</title>
			<pubDate><![CDATA[Fri, 22 Sep 2023 14:20:18 +0000]]></pubDate>
		</item>
					<item>
			<guid><![CDATA[https://bostonsp.com/index.php/clinical-trial-support-services/]]></guid>
			<link><![CDATA[https://bostonsp.com/index.php/clinical-trial-support-services/]]></link>
			<title>Clinical Trial Support Services</title>
			<pubDate><![CDATA[Fri, 22 Sep 2023 13:44:58 +0000]]></pubDate>
		</item>
					<item>
			<guid><![CDATA[https://bostonsp.com/index.php/artificial-intelligence/]]></guid>
			<link><![CDATA[https://bostonsp.com/index.php/artificial-intelligence/]]></link>
			<title>Artificial Intelligence</title>
			<pubDate><![CDATA[Fri, 22 Sep 2023 13:28:00 +0000]]></pubDate>
		</item>
					<item>
			<guid><![CDATA[https://bostonsp.com/index.php/2020/08/11/racial-differences-in-the-use-of-aortic-valve-replacement-for-treatment-of-symptomatic-severe-aortic-valve-stenosis-in-the-transcatheter-aortic-valve-replacement-era/]]></guid>
			<link><![CDATA[https://bostonsp.com/index.php/2020/08/11/racial-differences-in-the-use-of-aortic-valve-replacement-for-treatment-of-symptomatic-severe-aortic-valve-stenosis-in-the-transcatheter-aortic-valve-replacement-era/]]></link>
			<title>Racial Differences in the Use of Aortic Valve Replacement for Treatment of Symptomatic Severe Aortic Valve Stenosis in the Transcatheter Aortic Valve Replacement Era</title>
			<pubDate><![CDATA[Thu, 24 Aug 2023 19:46:11 +0000]]></pubDate>
		</item>
					<item>
			<guid><![CDATA[https://bostonsp.com/index.php/2022/03/31/comparison-of-patterns-of-use-and-clinical-outcomes-between-injections-of-testosterone-undecanoate-and-testosterone-cypionate-an-electronic-health-record-cohort-study/]]></guid>
			<link><![CDATA[https://bostonsp.com/index.php/2022/03/31/comparison-of-patterns-of-use-and-clinical-outcomes-between-injections-of-testosterone-undecanoate-and-testosterone-cypionate-an-electronic-health-record-cohort-study/]]></link>
			<title>Comparison of Patterns of Use and Clinical Outcomes Between Injections of Testosterone Undecanoate and Testosterone Cypionate: An Electronic Health Record Cohort Study</title>
			<pubDate><![CDATA[Thu, 24 Aug 2023 19:44:48 +0000]]></pubDate>
		</item>
					<item>
			<guid><![CDATA[https://bostonsp.com/index.php/2023/01/16/association-of-acei-arb-and-statin-prescribing-patterns-with-mortality-after-transcatheter-aortic-valve-replacement-tavr-findings-from-real-world-claims-data/]]></guid>
			<link><![CDATA[https://bostonsp.com/index.php/2023/01/16/association-of-acei-arb-and-statin-prescribing-patterns-with-mortality-after-transcatheter-aortic-valve-replacement-tavr-findings-from-real-world-claims-data/]]></link>
			<title>Association of ACEI/ARB and statin prescribing patterns with mortality after Transcatheter Aortic Valve Replacement (TAVR): Findings from real-world claims data</title>
			<pubDate><![CDATA[Thu, 24 Aug 2023 19:42:45 +0000]]></pubDate>
		</item>
					<item>
			<guid><![CDATA[https://bostonsp.com/index.php/2022/04/26/artificial-intelligence-enabled-predictive-model-of-progression-from-moderate-to-severe-aortic-stenosis/]]></guid>
			<link><![CDATA[https://bostonsp.com/index.php/2022/04/26/artificial-intelligence-enabled-predictive-model-of-progression-from-moderate-to-severe-aortic-stenosis/]]></link>
			<title>Artificial intelligence-enabled predictive model of progression from moderate to severe aortic stenosis</title>
			<pubDate><![CDATA[Thu, 24 Aug 2023 19:41:36 +0000]]></pubDate>
		</item>
					<item>
			<guid><![CDATA[https://bostonsp.com/index.php/2022/10/26/timely-albumin-improves-survival-in-patients-with-cirrhosis-on-diuretic-therapy-who-develop-acute-kidney-injury-real-world-evidence-in-the-united-states/]]></guid>
			<link><![CDATA[https://bostonsp.com/index.php/2022/10/26/timely-albumin-improves-survival-in-patients-with-cirrhosis-on-diuretic-therapy-who-develop-acute-kidney-injury-real-world-evidence-in-the-united-states/]]></link>
			<title>Timely Albumin Improves Survival in Patients With Cirrhosis on Diuretic Therapy Who Develop Acute Kidney Injury: Real-World Evidence in the United States</title>
			<pubDate><![CDATA[Thu, 24 Aug 2023 19:38:35 +0000]]></pubDate>
		</item>
					<item>
			<guid><![CDATA[https://bostonsp.com/index.php/2022/12/12/early-albumin-infusion-is-associated-with-greater-survival-to-discharge-among-patients-with-sepsis-septic-shock-who-develop-severe-acute-kidney-injury-among-patients-with-sepsis-septic-shock-who-devel/]]></guid>
			<link><![CDATA[https://bostonsp.com/index.php/2022/12/12/early-albumin-infusion-is-associated-with-greater-survival-to-discharge-among-patients-with-sepsis-septic-shock-who-develop-severe-acute-kidney-injury-among-patients-with-sepsis-septic-shock-who-devel/]]></link>
			<title>Early Albumin Infusion Is Associated With Greater Survival to Discharge Among Patients With Sepsis/Septic Shock Who Develop Severe Acute Kidney Injury Among Patients With Sepsis/Septic Shock Who Develop Severe Acute Kidney Injury</title>
			<pubDate><![CDATA[Thu, 24 Aug 2023 19:37:13 +0000]]></pubDate>
		</item>
					<item>
			<guid><![CDATA[https://bostonsp.com/index.php/2021/08/13/association-between-patient-survival-and-clinician-variability-in-treatment-rates-for-aortic-valve-stenosis/]]></guid>
			<link><![CDATA[https://bostonsp.com/index.php/2021/08/13/association-between-patient-survival-and-clinician-variability-in-treatment-rates-for-aortic-valve-stenosis/]]></link>
			<title>Association Between Patient Survival and Clinician Variability in Treatment Rates for Aortic Valve Stenosis</title>
			<pubDate><![CDATA[Fri, 08 Sep 2023 18:41:10 +0000]]></pubDate>
		</item>
					<item>
			<guid><![CDATA[https://bostonsp.com/index.php/2021/04/28/sex-disparities-in-patients-with-symptomatic-severe-aortic-stenosis/]]></guid>
			<link><![CDATA[https://bostonsp.com/index.php/2021/04/28/sex-disparities-in-patients-with-symptomatic-severe-aortic-stenosis/]]></link>
			<title>Sex disparities in patients with symptomatic severe aortic stenosis</title>
			<pubDate><![CDATA[Fri, 08 Sep 2023 18:38:33 +0000]]></pubDate>
		</item>
					<item>
			<guid><![CDATA[https://bostonsp.com/index.php/2022/01/07/evaluation-of-preanalytical-point-of-care-testing-errors-and-their-impact-on-productivity-in-the-emergency-department-in-the-united-states/]]></guid>
			<link><![CDATA[https://bostonsp.com/index.php/2022/01/07/evaluation-of-preanalytical-point-of-care-testing-errors-and-their-impact-on-productivity-in-the-emergency-department-in-the-united-states/]]></link>
			<title>Evaluation of Preanalytical Point-of-Care Testing Errors and Their Impact on Productivity in the Emergency Department in the United States</title>
			<pubDate><![CDATA[Fri, 08 Sep 2023 18:36:38 +0000]]></pubDate>
		</item>
					<item>
			<guid><![CDATA[https://bostonsp.com/index.php/2022/05/17/intraoperative-hypotension-is-associated-with-persistent-acute-kidney-disease-after-noncardiac-surgery-a-multicentre-cohort-study/]]></guid>
			<link><![CDATA[https://bostonsp.com/index.php/2022/05/17/intraoperative-hypotension-is-associated-with-persistent-acute-kidney-disease-after-noncardiac-surgery-a-multicentre-cohort-study/]]></link>
			<title>Intraoperative hypotension is associated with persistent acute kidney disease after noncardiac surgery: a multicentre cohort study</title>
			<pubDate><![CDATA[Fri, 08 Sep 2023 18:33:29 +0000]]></pubDate>
		</item>
					<item>
			<guid><![CDATA[https://bostonsp.com/index.php/2022/09/01/pegcetacoplan-versus-eculizumab-in-patients-with-paroxysmal-nocturnal-haemoglobinuria-pegasus-48-week-follow-up-of-a-randomised-open-label-phase-3-active-comparator-controlled-trial/]]></guid>
			<link><![CDATA[https://bostonsp.com/index.php/2022/09/01/pegcetacoplan-versus-eculizumab-in-patients-with-paroxysmal-nocturnal-haemoglobinuria-pegasus-48-week-follow-up-of-a-randomised-open-label-phase-3-active-comparator-controlled-trial/]]></link>
			<title>Pegcetacoplan versus eculizumab in patients with paroxysmal nocturnal haemoglobinuria (PEGASUS): 48-week follow-up of a randomised, open-label, phase 3, active-comparator, controlled trial</title>
			<pubDate><![CDATA[Fri, 08 Sep 2023 18:32:33 +0000]]></pubDate>
		</item>
					<item>
			<guid><![CDATA[https://bostonsp.com/index.php/2023/04/24/bacterial-transfer-and-biofilm-formation-in-needleless-connectors-in-a-clinically-simulated-in-vitro-catheter-model/]]></guid>
			<link><![CDATA[https://bostonsp.com/index.php/2023/04/24/bacterial-transfer-and-biofilm-formation-in-needleless-connectors-in-a-clinically-simulated-in-vitro-catheter-model/]]></link>
			<title>Bacterial transfer and biofilm formation in needleless connectors in a clinically simulated in vitro catheter model</title>
			<pubDate><![CDATA[Fri, 08 Sep 2023 18:31:31 +0000]]></pubDate>
		</item>
					<item>
			<guid><![CDATA[https://bostonsp.com/index.php/what-we-do/medical-and-technical-communications/]]></guid>
			<link><![CDATA[https://bostonsp.com/index.php/what-we-do/medical-and-technical-communications/]]></link>
			<title>Medical and Technical Communications</title>
			<pubDate><![CDATA[Thu, 03 Aug 2023 02:37:46 +0000]]></pubDate>
		</item>
					<item>
			<guid><![CDATA[https://bostonsp.com/index.php/interactive-tools-data-visualization/]]></guid>
			<link><![CDATA[https://bostonsp.com/index.php/interactive-tools-data-visualization/]]></link>
			<title>Interactive Tools &amp; Data Visualization</title>
			<pubDate><![CDATA[Fri, 22 Sep 2023 14:15:34 +0000]]></pubDate>
		</item>
					<item>
			<guid><![CDATA[https://bostonsp.com/index.php/selected-publications-leveraging-ehr-data/]]></guid>
			<link><![CDATA[https://bostonsp.com/index.php/selected-publications-leveraging-ehr-data/]]></link>
			<title>Selected Publications Leveraging EHR Data</title>
			<pubDate><![CDATA[Thu, 03 Aug 2023 01:51:04 +0000]]></pubDate>
		</item>
					<item>
			<guid><![CDATA[https://bostonsp.com/index.php/what-we-do/health-economics-and-outcomes-research/]]></guid>
			<link><![CDATA[https://bostonsp.com/index.php/what-we-do/health-economics-and-outcomes-research/]]></link>
			<title>Health Economics and Outcomes Research</title>
			<pubDate><![CDATA[Thu, 03 Aug 2023 01:41:04 +0000]]></pubDate>
		</item>
					<item>
			<guid><![CDATA[https://bostonsp.com/index.php/comprehensive-heor-support/]]></guid>
			<link><![CDATA[https://bostonsp.com/index.php/comprehensive-heor-support/]]></link>
			<title>Comprehensive HEOR Support</title>
			<pubDate><![CDATA[Fri, 22 Sep 2023 13:49:28 +0000]]></pubDate>
		</item>
				</channel>
</rss>
